CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale CEO, President and Secretary sold 473,250 shares at $30.83 ($14,589,493)
- 4 Open-market sale Director sold 473,250 shares at $30.83 ($14,589,493)
- 4 Open-market sale 10% owner sold 473,250 shares at $30.83 ($14,589,493)
- 4 Open-market sale 10% owner sold 473,250 shares at $30.83 ($14,589,493)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 23 of 34 · 672 filings